| 发明名称 |
MTK1-ACTIN INHIBITORS AND METHODS OF USE |
| 摘要 |
One aspect of the invention provides a method for treating a clinical condition associated with inappropriate or abnormal activation of HER3/ErbB3. In some embodiments, the method of the invention inhibits interaction between MTK1 and actin. |
| 申请公布号 |
US2015045407(A1) |
申请公布日期 |
2015.02.12 |
| 申请号 |
US201414453497 |
申请日期 |
2014.08.06 |
| 申请人 |
Vaillancourt Richard R.;Sollome James J. |
发明人 |
Vaillancourt Richard R.;Sollome James J. |
| 分类号 |
A61K31/403;G01N33/50 |
主分类号 |
A61K31/403 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating a subject suffering from a clinical condition associated with activation of HER3/ErbB3, said method comprising:
administering to said subject a therapeutically effective amount of a compound that inhibits interaction between actin and mitogen-activated protein three kinase (MTK1). |
| 地址 |
Tucson AZ US |
